Acute coronary syndrome and stable coronary artery disease: Are they so different? Long-term outcomes in a contemporary PCI cohort

Are BVS suitable for ACS patients? Support from a large single center real live registry

“…Rate of mortality in ACS patients is worse compared with patients who present with stable CAD [42][43][44][45]. In our patient cohort, mortality was 0% in the ACS population probably reflecting our exclusion criteria for the STEMI population (exclusion of patients presenting with cardiogenic shock).…”

Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome

“…We are also aware, that heterogeneity of included subgroups regarding cardiovascular outcome (i.e. overall low event rate in stable patients vs. higher event rate in ACS patients) might underpower the observed associations and the prognostic impact of TGF-b1 expression in particular subgroups of cardiovascular patients [30]. However, it has been a common and accepted approach to include different conditions of cardiovascular disease as control (i.e.…”

Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention

“…After percutaneous coronary intervention (PCI), RF is independently associated with mortality and other adverse events in patients with CAD [5]. Patients undergoing PCI for ACS are known to have a poorer short-term prognosis compared with sCAD patients [6]. RF is an independent predictor of all-cause mortality for both ACS and sCAD patients undergoing PCI [6].…”

“…Patients undergoing PCI for ACS are known to have a poorer short-term prognosis compared with sCAD patients [6]. RF is an independent predictor of all-cause mortality for both ACS and sCAD patients undergoing PCI [6]. Because patients with RF have been systematically excluded from clinical trials [7], the prevalence and outcomes of patients with RF have not been well studied in the PCI setting.…”